Replies to post #108469 on Anavex Life Sciences Corp (AVXL)

[kld2]

Couldn't agree more. Anything one has is always different/better than the next person. Hate to break it to you, but Missling is like any other bioech CEO: trying to keep the company afloat while taking his "shot in the dark."

[TheBigTicket]

I agree totally--i have lost so much $$ over the years in small biotechs and they are always the same. They don't have enough $$ for trials, they are waiting on the elusive "magic" data, etc. We have to question Missling and stay on him--hold the company accountable. Cannot just blindly follow any of these CEO's.

[williamssc]

No date was ever set on PK release. Company and FDA may have data right now and are using it to guide set up of phase3 trial . All bio's have dates slip especially one with multiple irons in the fire.

[apostrophe]

re:" In biotechs - certain steps such as pk/pd data have expected timelines - and if companies start slipping them - assume that something is wrong "

Nothing is wrong. Posters complaining that they want pk/pd data - do they even know what thay are asking for? Below is an example of pk/pd data - there will be hundreds of pages like that for each patient. It's meaningless and irrelevant to an investor.